SCHEMBL5301397

SCHEMBL5301397

CCCCCCCCCC[n+]1cc[nH]c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.52
ADRA2A P08913 2/20 0.52
ADORA3 P0DMS8 2/20 0.52
CHRM1 P11229 2/20 0.52
ACHE P22303 2/20 0.52
SLC6A2 P23975 2/20 0.52
SLC6A4 P31645 2/20 0.52
SLC6A3 Q01959 2/20 0.52
ABCB11 O95342 1/20 0.52
ESR1 P03372 1/20 0.52
PGR P06401 1/20 0.52
HTR1A P08908 1/20 0.52
DRD1 P21728 1/20 0.52
TBXA2R P21731 1/20 0.52
PTGS1 P23219 1/20 0.52
PDE4A P27815 1/20 0.52
ADRA1A P35348 1/20 0.52
OPRM1 P35372 1/20 0.52
DRD3 P35462 1/20 0.52
KCNH2 Q12809 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29914959 1.00 CHRM2 (0.52) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL3723655 1.00 CHRM2 (0.52) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL345304 1.00 CHRM2 (0.52) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL4058948 1.00 CHRM2 (0.52) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL5295356 1.00 CHRM2 (0.52) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL5300351 1.00 CHRM2 (0.52) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL5299619 1.00 CHRM2 (0.52) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL4226778 1.00 CHRM2 (0.52) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL5297852 1.00 CHRM2 (0.52) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL2944932 1.00 CHRM2 (0.52) CHRM2ADRA2AADORA3CHRM1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2690501-B1 CONDUCTIVE MEMBER FOR ELECTROPHOTOGRAPHY CANON KK (JP) 2018-01-10 EP disclosed
EP-2474527-B1 IONIC LIQUID CONTAINING ALLYLSULFONATE ANION WAKO PURE CHEM IND LTD (JP) 2017-01-25 EP disclosed
US-9128403-B2 Electrophotographic electrically conductive member CANON KABUSHIKI KAISHA (JP) 2015-09-08 US disclosed
US-20140178096-A1 ELECTROPHOTOGRAPHIC ELECTRICALLY CONDUCTIVE MEMBER CANON KABUSHIKI KAISHA (JP) 2014-06-26 US disclosed
US-8668987-B2 Electrophotographic electrically conductive member CANON KABUSHIKI KAISHA (JP) 2014-03-11 US disclosed
EP-2690501-A1 CONDUCTIVE MEMBER FOR ELECTROPHOTOGRAPHY Canon Kabushiki Kaisha (JP) 2014-01-29 EP disclosed
US-8546609-B2 Ionic liquid containing allylsulfonate anion WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2013-10-01 US disclosed
US-20120263499-A1 ELECTROPHOTOGRAPHIC ELECTRICALLY CONDUCTIVE MEMBER CANON KABUSHIKI KAISHA (JP) 2012-10-18 US disclosed
EP-2474527-A1 IONIC LIQUID CONTAINING ALLYLSULFONATE ANION Wako Pure Chemical Industries, Ltd. (JP) 2012-07-11 EP disclosed
US-20120157680-A1 IONIC LIQUID CONTAINING ALLYLSULFONATE ANION WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2012-06-21 US disclosed
EP-1538183-B1 THERMOPLASTIC FILM, THERMOPLASTIC RESIN COMPOSITION, AND PHYLLOSILICATE TEIJIN LTD (JP) 2007-10-31 EP disclosed
US-7189782-B2 Thermoplastic film, thermoplastic resin composition, and phyllosilicate TEIJIN LIMITED (JP) 2007-03-13 US disclosed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 WO disclosed
EP-1538183-A1 THERMOPLASTIC FILM, THERMOPLASTIC RESIN COMPOSITION, AND PHYLLOSILICATE TEIJIN LIMITED (JP) 2005-06-08 EP disclosed
US-20050089698-A1 Thermoplastic film, thermoplastic resin composition, and phyllosilicate TEIJIN LIMITED (JP) 2005-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157680-A1 IONIC LIQUID CONTAINING ALLYLSULFONATE ANION ATXN2L, ARL1, INPPL1 CHRM2 2122/4885ADRA2A 2859/4885ADORA3 133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.